Melashchenko O. I., Kaliuzhka O. O., Ziuzina L. S., Fastovets M. M., Kozakevych V. K.

LITERATURE REVIEWS

Scentific article

A review of modern scientific sources has shown that the treatment of children with recurrent respiratory diseases (RRD) on the background of pharyngeal tonsil hyperplasia (PTH) requires a comprehensive and personalized approach that takes into account the child’s age, etiology, period and course of the disease, concomitant conditions, degree of hypertrophy and bacterial complications in the anamnesis. Drugs must be safe and with proven effectiveness. The functioning of adenoids involves the accumulation of microbial antigens. Therefore, treatment measures for adenoiditis and preventive measures to prevent RRD in children with adenoids should be aimed at cleaning the mucous membranes and elimination of pathogenic and conditionally pathogenic microflora, which is achieved through the use of nasal irrigations with saline solutions NaCl or sterile sea water. In modern conditions, in order to reduce inflammation, edema and adenoids’ size, destruction of bacterial biofilms on the surface of the pharyngeal tonsil, the use of endonasal glucocorticoid steroids has been proven, the safest of which is mometasone furoate. Tactics of management of children with adenoid hyperplasia should promote acceleration of the reparation of the epithelium and restore the cytoarchitectonics of the nasopharyngeal mucosa, which is achieved by using an endonasal drug based on a colloidal solution of silver, Iceland moss extract and D-panthenol. To reduce respiratory morbidity, it is recommended to increase the resistance of child’s organism to viral and bacterial infections by activating the mechanisms of production of antimicrobial peptides and restoring the eubiotic condition of the microflora of the respiratory tract’s mucosa, that is achieved by using the symbiotic FLUVIR.

recurrent respiratory diseases, children, the pharyngeal tonsil hyperplasia (adenoids), adenoiditis.

1. Tsvirenko SM, Artiomova NS, Ananevych OI, Adruschenko II, Bеlan OV. Osoblyvosti proiaviv hostrykh respiratornykh zakhvoriuvan u ditei rannoho viku. Aktualʹni problemy suchasnoyi medytsyny: Visnyk Ukrayinsʹkoyi medychnoyi stomatolohichnoyi akademiyi. 2019;19(4):38-42. Dostupno: https://doi. org/10.31718/2077-1096.19.4.38 [in Ukrainian].
2. Chernyshova LI. Rekurentni respiratorni zakhvoriuvannia u ditei: alhorytm dii likaria (lektsiia). Sovremennaya pediatriya. 2018;3(91):92-7. DOI: 10.15574/SP.2018.91.92 [in Ukrainian].
3. Yurochko F. Retsydyvuiuchi respiratorni infektsii u ditei. Sovremennaya pediatriya. 2013;5:91-6. Dostupno: http://nbuv.gov.ua/UJRN/Sped_2013_5_19 [in Ukrainian].
4. Beketova GV, Soldatova ОV. Mozhlyvosti mistsevoi imunomoduliuiuchoi ta reparatyvnoi terapii v ditei z rekurentnymy zakhvoriuvanniamy respiratornoho traktu i porozhnyny rota. Sovremennaya pediatriya. 2018;2(90):110-3. Dostupno: http://nbuv.gov.ua/UJRN/Sped_2018_2_18 [in Ukrainian].
5. Bezshapochnyiy SB, Gasyuk YuA, Smeyanov EV. Giperplaziya i vospalenie glotochnoy mindalinyi. Kiev: Logos; 2017. 123 s. [in Russian].
6. Lezhenko HO, Abaturov OIe, Pashkova OIe. Rol endohennykh antymikrobnykh peptydiv u bakterialnii kolonizatsii nosohlotky v ditei iz hiperplaziieiu retronazalnoi myhdalyny. Zdorove rebenka. Dostupno: http://dspace.zsmu.edu.ua/handle/123456789/52442016;6:74-80 [in Ukrainian].
7. Cho KS, Kim SH, Hong SL, Lee J, Mun SJ, Roh YE, et al. Local Atopy in Childhood Adenotonsillar Hypertrophy. Am J Rhinol Allergy. 2018 May;32(3):160-6.
8. Evcimik MF, Dogru M, Cirik AA, Nepesov MI. Adenoid hypertrophy in children with allergic disease and influential factors. Int J Pediatr Otorhinolaryngol. 2015 May;79(5):694-7. DOI: 10.1016/j.ijporl.2015.02.017
9. Lemko OI, Lukashchuk SV. Rekurentni respiratorni zakhvoriuvannia u praktytsi simeinoho likaria ta pediatra: osnovni pytannia (ohliad literatury). Zaporozhskiy meditsinskiy zhurnal. 2019;21(6):835-42. [in Ukrainian].
10. Fesenko MYе, Zyuzina LS, Fastovets MM, Kalyuzhka OO, Melashchenko OI. Hostri respiratorni rekurentni infektsii u ditei. Aktualʹni problemy suchasnoyi medytsyny: Visnyk Ukrayinsʹkoyi medychnoyi stomatolohichnoyi akademiyi. 2019;19(4):34-8. Dostupno: https://doi.org/10.31718/2077-1096.19.4.34 DOI: 10.14739/2310-1210.2019.6.186715 [in Ukrainian].
11. Tkachenko VYu. Osobennosti techeniya ostryih respiratornyih zabolevaniy u detey s giperplaziey limfoglotochnogo koltsa. Sovremennaya pediatriya. 2016;2(74):89-91. DOI: 10.15574/SP.2016.74.89 [in Russian].
12. Ovcharenko LS, Tkachenko VYu, Vertehel AO, Andriienko TH, Samokhin IV, Kriazhev OV, ta in. Vplyv hiperplazii adenoidiv ta adenotomii na imunitet i stan zdorovia ditei. Zdorove rebenka. 2017;4:514-20. Dostupno: http://nbuv.gov.ua/UJRN/Zd_2017_12_4_16 [in Ukrainian].
13. van den Aardweg MT, Boonacker CW, Rovers MM, Hoes AW, Schilder AG. Effectiveness of adenoidectomy in children with recurrent upper respiratory tract infections: open randomised controlled trial. BMJ. 2011 Sep 6;343:d5154. DOI: 10.1136/bmj.d5154
14. Kvaerner KJ. Adenoidectomy in children with recurrent upper respiratory infections. BMJ. 2011 Sep 6;343:d5274. DOI: 10.1136/bmj.d5274
15. Bezshapochnyi SB, Sonnik NB, Loburets VV, Vakhnina AP. Optymalnyi pidkhid ta farmakoterapiia tryvalykh adenoidytiv u ditei. Zhurn. vush. nos. i horl. khvorob. 2009;3:14-5. [in Ukrainian].
16. Nesterova AA. Organosohranyayuschee kompleksnoe lechenie hronicheskogo adenoidita. [dissertatsiya]. Omsk: Omskij gosudarsvennyj medicinskij universitet; 2019. 133 s. [in Russian].
17. Yurochko F, Kopanska D. Suchasne khirurhichne i medykamentozne likuvannia khvorob adenoidiv. Otorynolarynholohiia. 2018;2:87-93. [in Ukrainian].
18. Bulfamante AM, Saibene AM, Felisati G, Rosso C, Pipolo C. Adenoidal Disease and Chronic Rhinosinusitis in Children-Is there a Link? J Clin Med. 2019 Sep 23;8(10):1528. DOI: 10.3390/jcm8101528
19. Scadding G. Non-surgical treatment of adenoidal hypertrophy: the role of treating IgE-mediated inflammation. Pediatr Allergy Immunol. 2010;21(8):1095-106. DOI: 10.1111/j.1399-3038.2010.01012.x
20. Pereira L, Monyror J, Almeida FT, Almeida FR, Guerra E, Flores-Mir C, Pachêco-Pereira C. Prevalence of adenoid hypertrophy: A systematic review and meta-analysis. Sleep Med Rev. 2018 Apr;38:101-12. DOI: 10.1016/j.smrv.2017.06.001
21. Belcher R, Virgin F. The Role of the Adenoids in Pediatric Chronic Rhinosinusitis. Med Sci (Basel). 2019;7(2):35. Published 2019 Feb 25. DOI: 10.3390/ medsci7020035
22. Chohan A, Lal A, Chohan K, Chakravarti A, Gomber S. Systematic review and meta-analysis of randomized controlled trials on the role of mometasone in adenoid hypertrophy in children. Int J Pediatr Otorhinolaryngol. 2015 Oct;79(10):1599-608. DOI: 10.1016/j.ijporl.2015.07.009
23. Bayazian G, Sayyahfar S, Safdarian M, Kalantari F. Is there any association between adenoid biofilm and upper airway infections in pediatric patients? Turk Pediatri Ars. 2018;53(2):71-7. Published 2018 Jun 1. DOI: 10.5152/TurkPediatriArs.2018.6151
24. Torretta S, Drago L, Marchisio P, Ibba T, Pignataro L. Role of Biofilms in Children with Chronic Adenoiditis and Middle Ear Disease. Clin Med. 2019 May 13;8(5):671. DOI: 10.3390/jcm8050671
25. Ghafar MHA, Mohamed H, Mohammad NMY, Mohammad ZW, Madiadipoera T, Wang Y, et al. Mometasone furoate intranasal spray is effective in reducing symptoms and adenoid size in children and adolescents with adenoid hypertrophy. Acta Otorrinolaringol Esp. 2020;71(3):147-53. DOI: 10.1016/j.otorri.2019.04.004
26. Kar M, Altıntoprak N, Muluk NB, Ulusoy S, Bafaqeeh SA, Cingi C. Antileukotrienes in adenotonsillar hypertrophy: a review of the literature. Eur Arch Otorhinolaryngol. 2016 Dec;273(12):4111-7. DOI: 10.1007/s00405-016-3983-8
27. Singh R, Shilpa R, Mukhopadhyay C, Shenoy PA, Balakrishnan R, Devaraja K. Correlation Between Microbiological Profiles of Adenoid Tissue and Nasal Discharge in Children with Co-existent Chronic Adenoiditis and Chronic Rhinosinusitis. Indian J Otolaryngol Head Neck Surg. 2020;72(1):112-6. DOI: 10.1007/s12070-019-01775-y
28. Tsodikova OA, Sereda HS. Mukozalnyi imunitet u ditei iz hiperplaziieiu limfohlotkovoho kiltsia. Dytiachyi likar. 2017;2(53):32-8. [in Ukrainian].
29. Dąbrowska-Leonik N, Bernatowska E, Pac M, Filipiuk W, Mulawka J, Pietrucha B, et al. Vitamin D deficiency in children with recurrent respiratory infections, with or without immunoglobulin deficiency. Adv Med Sci. 2018 Mar;63(1):173-8. DOI: 10.1016/j.advms.2017.08.001
30. Kriuchko TO, Kushnereva TV, Kharshman VP, Kuzmenko NV. Obgruntuvannia symptomatychnoi terapii respiratorno-virusnykh infektsii u ditei. Sovremennaya pediatriya. 2019;1(97):117-22. [in Ukrainian].
31. Popovych VI, Beketova HV, Koshel IV, Tsodikova OA, Kriuchko TA, Abaturov AE, et al. An open-label, multicentre, randomized comparative study of efficacy, safety and tolerability of the 5 plant – extract BNO 1012 in the Delayed Antibiotic Prescription Method in children, aged 6 to 11 years with acute viral and post-viral rhinosinusitis. Am J Otolaryngol. 2020 Sep-Oct;41(5):102564. DOI: 10.1016/j.amjoto.2020.102564
32. Li L, Wang F, Liu Y, Gu F. Intestinal microbiota dysbiosis in children with recurrent respiratory tract infections. Microb Pathog. 2019 Nov;136:103709. DOI: 10.1016/j.micpath.2019.103709
33. Amaral MA, Guedes GHBF, Epifanio M, Wagner MB, Jones MH, Mattiello R. Network meta-analysis of probiotics to prevent respiratory infections in children and adolescents. Pediatr Pulmonol. 2017;52(6):833-43. Available from: https://doi.org/10.1002/ppul.23643
34. Marushko YuV, Movchan OS, Zelena NA, Iovitsa TV. Dosvid zastosuvannia symbiotyka fluvir, u ditei na etapi reabilitatsii pislia hostrykh respiratornykh zakhvoriuvan. Sovremennaya pediatriya. 2013;5(53):128-33. [in Ukrainian].

«Bulletin of problems biology and medicine» Issue 4 (158), 2020 year, 35-39 pages, index UDK 616.9:616.21-053.2-085

10.29254/2077-4214-2020-4-158-35-39